Sea Mild Biotechnology Co., Ltd. (TPEX:7516)
Taiwan · Delayed Price · Currency is TWD 8.65
-0.11 (-1.26%)
Aug 14, 2026, 1:13 PM CST
Sea Mild Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 89.2 | 82.94 | 46.63 | 40.58 | 38.95 |
Cash & Short-Term Investments | 89.2 | 82.94 | 46.63 | 40.58 | 38.95 |
Cash Growth | 7.54% | 77.89% | 14.91% | 4.19% | -25.20% |
Accounts Receivable | 79.62 | 63.62 | 58.26 | 57.67 | 50.53 |
Receivables | 79.62 | 63.62 | 58.26 | 57.67 | 50.53 |
Inventory | 68.19 | 58.01 | 28.81 | 16.77 | 21.14 |
Prepaid Expenses | 10.47 | 3.1 | 7.16 | 1.38 | 2.47 |
Other Current Assets | 10.55 | 8.74 | 9.99 | 6.99 | 0.03 |
Total Current Assets | 258.03 | 216.42 | 150.84 | 123.39 | 113.11 |
Property, Plant & Equipment | 58.97 | 24.9 | 23.2 | 27.29 | 43.23 |
Other Intangible Assets | - | - | 0.03 | 0.31 | 0.71 |
Long-Term Deferred Tax Assets | 0.96 | 0.91 | 1.86 | 1.81 | 1.7 |
Other Long-Term Assets | 7.97 | 13.89 | 14.44 | 4.88 | 9.5 |
Total Assets | 325.92 | 256.11 | 190.36 | 157.69 | 168.23 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 73.61 | 65.24 | 50.32 | 46.48 | 37.37 |
Accrued Expenses | 12.39 | 14.37 | 8.46 | 7.35 | 8.11 |
Short-Term Debt | 50 | 30 | 25 | 3.05 | - |
Current Portion of Long-Term Debt | 8.88 | 16.67 | - | - | - |
Current Portion of Leases | 13.05 | 6.83 | 12.91 | 10.65 | 7.84 |
Current Unearned Revenue | 0.58 | 0.61 | 0.33 | 0.65 | 1.38 |
Other Current Liabilities | 19.27 | 16.06 | 16.6 | 13.36 | 10.4 |
Total Current Liabilities | 177.78 | 149.78 | 113.61 | 81.55 | 65.1 |
Long-Term Debt | 13.58 | 3.33 | - | - | - |
Long-Term Leases | 23.93 | 0.59 | 6.34 | 11.65 | 17.32 |
Long-Term Deferred Tax Liabilities | 0 | - | 0 | 0.02 | - |
Other Long-Term Liabilities | 0.01 | 0.01 | - | - | - |
Total Liabilities | 215.31 | 153.71 | 119.96 | 93.21 | 82.41 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 193.09 | 193.09 | 193.09 | 193.09 | 193.09 |
Retained Earnings | -81.86 | -90.7 | -122.68 | -128.87 | -107.49 |
Comprehensive Income & Other | -0.62 | - | - | 0.27 | 0.22 |
Total Common Equity | 110.61 | 102.39 | 70.41 | 64.48 | 85.82 |
Shareholders' Equity | 110.61 | 102.39 | 70.41 | 64.48 | 85.82 |
Total Liabilities & Equity | 325.92 | 256.11 | 190.36 | 157.69 | 168.23 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 109.44 | 57.42 | 44.25 | 25.35 | 25.16 |
Net Cash (Debt) | -20.24 | 25.52 | 2.38 | 15.23 | 13.79 |
Net Cash Growth | - | 974.65% | -84.40% | 10.45% | -23.54% |
Net Cash Per Share | -1.05 | 1.32 | 0.12 | 0.79 | 0.71 |
Filing Date Shares Outstanding | 19.31 | 19.31 | 19.31 | 19.31 | 19.31 |
Total Common Shares Outstanding | 19.31 | 19.31 | 19.31 | 19.31 | 19.31 |
Working Capital | 80.24 | 66.64 | 37.23 | 41.85 | 48.01 |
Book Value Per Share | 5.73 | 5.30 | 3.65 | 3.34 | 4.44 |
Tangible Book Value | 110.61 | 102.39 | 70.37 | 64.17 | 85.11 |
Tangible Book Value Per Share | 5.73 | 5.30 | 3.64 | 3.32 | 4.41 |
Machinery | 92.43 | 78.6 | 67.32 | 66.07 | 67.04 |